Clinical Trial Update: Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

View source ↗

Summary

This clinical trial is currently recruiting to evaluate stroke risk assessment and biomarkers of blood clotting in adults with newly diagnosed non-valvular atri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Non-valvular Atrial Fibrillation
• Stroke

Snippet

Sponsor: Nedim Tojaga | Conditions: Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke) | Status: RECRUITING